On behalf of BioStem Technologies, we wish you a happy and safe St. Patrick’s Day! #BSEM #BioStem #BioStemTechnologies #AdvancedWoundCare #Biotech BioStem Technologies Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care. Visit https://ow.ly/JKrI50QnsIi to learn more about us! Here are four fun facts about four-leaf clovers: There are approximately 10,000 three-leaf clovers for every "lucky" four-leaf clover. The leaves of four-leaf clovers are said to stand for faith, hope, love, and luck. It's often said that Ireland is home to more four-leaf clovers than any other place, giving meaning to the phrase "the luck of the Irish." If you're the superstitious type, give your four-leaf clover to someone else. It's said that this will double your good luck.
BioStem Technologies (OTC: BSEM)’s Post
More Relevant Posts
-
On behalf of BioStem Technologies, we wish you a happy Father’s Day! #BSEM #BioStem #BioStemTechnologies #AdvancedWoundCare #Biotech #CuttingEdge #RegenerativeMedicine About Us: BioStem Technologies, Inc. (OTC: BSEM) is a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care. Visit https://ow.ly/NT3750Qnwp7 to learn more about us! Three fun facts about Father’s Day: Washington was the first state to celebrate Father's Day. Father’s Day wasn't officially recognized as a national holiday until 1972. Surprisingly, the trusty slipper gift isn’t the most popular Father's Day present – it’s actually a tie.
-
-
Biotech Patent Attorney (founder of Double Helix Law) who has dedicated his 30+ yr career to biopharma (Co-Founder of BPIQ.com and BiopharmIQ.com)
The biggest cancer biomed meeting of the year, #ASCO2024 started yesterday. Of the ~6,000 presentations, our biopharmIQ team identified 77 clinical readouts from biopharma companies. Plus, we created a powerful free tool for identifying target abstracts, authors, and their organization. Check out this post for more info. Interesting how many more of the cancer clin readouts are for solid tumors vs. blood cancers (7 of 77 are for blood cancers). Of course, great progress has been made on treating many of the blood cancers. Maybe there aren't as many blood cancer clinical readouts at ASCO because most of those presentations occur at the ASH meeting in December?
Co-Founder @ BiopharmIQ - Bio/Pharma data for business development and investors. Helping biotech sales/BD teams uncover more potential partners utilizing data.
#ASCO2024 starts today! We identified 77 biopharma Clinical Readouts out of ~6,000 presentations To save you time See 📸 📸 📸 📸 for data 👇 --- 👋 I'm Dominic Vacchiano, Co-founder of BiopharmIQ by Amp. We provide biopharma data to help with your BD/investing activities. 📰 Each week we share clinical/regulatory/funding news in an easy-to-digest format. #biotech #biopharma #ASCO2024
-
📢 Don’t miss out on tomorrow’s webinar on optimizing TFF with biopharma #pumps! Even if you can't make it live, register to get the recording! 📅https://bit.ly/3XXDta3 #VERDOT #TFFOptimization #Biopharma #Quattroflow #GeneTherapy #Bioprocessing
Our webinar on how to optimize TFF with biopharma #pumps is tomorrow! ! Join us to learn how VERDOT achieved impressive results with their FlexiPro™ TFF system using pumps from Quattroflow, a PSG Biotech brand, to ensure gentle and efficient processing for high-quality outcomes. All registered attendees will receive a recording of the webinar afterwards, so be sure to register even if you’re unsure whether you can attend live! https://bit.ly/3XXDta3 👈 #PSGBiotech #PSGDover
-
-
Come hear me and Emily Heffernan, PE talk about “Design Considerations for Multi-Modal Facilities” at the PDA Southeast Chapter next week!
Please join Emily Heffernan, PE and Shwetha Ravi Devine, MS’s presentation, “Design Considerations for Multi-Modal Facilities,” on June 20th at 1:50 pm at the PDA - Parenteral Drug Association Southeast Chapter’s Spring Conference at the NC Biotech Center. Register here: https://ow.ly/zgqC50SgGN3
-
-
A critical issue for all emerging biopharmaceutical companies is their valuation- and how clinical trial results from their assets impact on that. This #IQVIA webinar discusses original research by IQVIA statistically analysing the link between valuation changes for biotech companies and types of clinical trials outcomes announcements. Recommended for a statistically robust, quantitative approach to a key #Biotech business issue.
Join our panel of speakers in this live webinar tomorrow as they discuss how to maximise biopharma valuations, considering investors’ prior expectations, development phase at readout, therapy area, and trial design. Register now to secure your spot. https://bit.ly/3zMCnph #biotech #emergingbiopharma
-
-
Learn the art of maintaining a biological system’s microbial allies! In the third and final installment of Seen & Solved’s “The Power of Biologics” series, with Product Manager of Biologics, Jeremy Morgan. Operating a biological system has its quirks, so tune in to learn all the necessary tips and tricks! https://bit.ly/4c8NreX
-
-
ASIA Region Head at Wacker Biosolutions. Selling 1st class B2B products & solutions to Partners (API | Biopharma CDMO | pDNA & mRNA | Precision Fermentation | Nutraceuticals | Functional Ingredients | Fine Chemicals)
Whether virtually or presentially, always ready to connect and share with you how our Biopharma CDMO experts can take your precious project to new heights! All the way long, from early development to commercial stage. #BiopharmaCDMO #CDMO #Biologics #Innovation #mRNA #pDNA #CGT #Peptides #recombinantproteins #vaccines #biotech #biotechnology
Join Wacker Biotech on Thursday, June 13, 2024 for CDMO Live, a completely virtual one-day gathering focused exclusively on biopharma contract development and manufacturing outsourcing. We are pleased to be participating in this event, which is organized by PharmaSource and includes 1:1 meeting opportunities if you would like to discuss your project needs with us. We look forward to meeting you online! Those active in this space can register here: http://wch.ag/N9Dk6 Your Wacker Biotech Team #CDMO #contractmanufacturing #biotech #biopharma #WackerBiotech
-
Thoughts on this? >> Roivant to 'unveil' pipeline addition next month; Bavarian Nordic gets $156M from US >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #pharmaceutical #pharma #productmarketing
Roivant to 'unveil' pipeline addition next month; Bavarian Nordic gets $156M from US
endpts.com
-
Cryopreservation is key for advanced therapies, but it’s only as good as the single-use bags and components you use. In my latest article, “Four Common Types of Cryogenic Studies for Advanced Therapies,” I break down why these studies matter and how to pick the right supplier to handle the freeze/thaw process. Check it out!
#ICYMI Cryopreservation is a critical step in the manufacture of advanced, life-saving therapies. But its success depends on how well single-use bags and components used in biopharma manufacturing can perform during the freeze/thaw process. Check out Eric Hennessy's new article, “Four Common Types of Cryogenic Studies for Advanced Therapies” to learn why these studies are so essential to building successful biopharma processes. You’ll also learn how therapy manufacturers can identify a single-use supplier who can help navigate the complexities of cryopreservation. Read now: https://lnkd.in/eUHeG-Nt #CharterMedical #singleuse #singleusesolutions #cryopreservation #freezingstudies #celltherapy #biopharma
-
-
Unleash the power of virtual screening and transform your drug discovery process with Jubilant Biosys. Get in touch with our experts to find out how we can make a difference in your drug discovery journey. Please write to: bd@jubilantbiosys.com to know more about our virtual screening services. #CRO #CDMO #CRDMO #drugdiscovery #innovation #computationalchemistry #medicinalchemistry
-
☘️